Emory University Hospital Adopts Microbot Medical's LIBERTY Endovascular Robotic System
Emory University Hospital is the first to adopt Microbot Medical's LIBERTY Endovascular Robotic System for its interventional radiology program. The system, FDA cleared and remotely operated, is designed for peripheral endovascular procedures. This adoption is part of a collaboration to establish an Endovascular Robotics Program, following a limited market release and ahead of a full release in April 2026.
Microbot Medical Inc. announced that Emory University Hospital has become the first hospital in the world to adopt the LIBERTY Endovascular Robotic System for patient care. The hospital will use the system in its interventional radiology program and collaborate with Microbot to establish an Endovascular Robotics Program. The LIBERTY system is FDA cleared, single-use, and remotely operated, designed for peripheral endovascular procedures. This adoption follows the company’s recent limited market release of the system and plans for a full market release in April 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9592793-en) on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
